News

Samsung Bioepis Co., Ltd. and Biogen Inc. announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for SB11, a proposed biosimilar referencing Lucentis® (ranibizumab). Ranibizumab is an anti-VEGF (vascular endothelial growth factor) for...

The maker of the first antiviral drug to get authorization from regulators for Covid-19 anticipates meeting real-time demand for it around the world this month and is already meeting demand in the U.S. Foster City, California-based Gilead Sciences said Thursday...

DuPont announced it will participate in the virtual CPhI: Festival of Pharma, highlighting its commitment to meet customers’ needs for essential innovations to address the challenges of the COVID-19 global pandemic. DuPont’s technical leaders will draw upon their decades of...

ValGenesis Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), announced that it has digitized the validation process at Dr. Reddy's Laboratories across multiple sites, driven by ValGenesis VLMS – the industry's most trusted electronic validation lifecycle...

Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO manufacturer of biological materials and pharmaceuticals, and Scancell Holdings plc (Scancell), the developer of novel immunotherapies for the treatment of cancer and infectious disease, announced that they...

Americans Harvey J. Alter and Charles M. Rice, and British scientist Michael Houghton were awarded the Nobel Prize for Medicine or Physiology on Monday for the discovery of the hepatitis C virus. Announcing the prize in Stockholm on Monday, the...

During the virtual CPhI Festival of Pharma (5–16 October), BENEO will showcase galenIQ 721 for probiotic supplements. galenIQ 721 is the agglomerated form of BENEO’s pharmaceutical-grade Isomalt. Supporting the viability of micro-organisms, the sweet-tasting excipient is suitable for probiotic powders,...